2-hydroxychavicol has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, I; Dutt, P; Khan, IA; Prasad, R; Satti, NK | 1 |
| Bani, S; Pandey, A | 1 |
2 other study(ies) available for 2-hydroxychavicol and Disease Models, Animal
| Article | Year |
|---|---|
Hydroxychavicol: A phytochemical targeting cutaneous fungal infections.
Topics: Administration, Topical; Animals; Antifungal Agents; Biofilms; Candida parapsilosis; Candidiasis; Dermatomycoses; Disease Models, Animal; Dose-Response Relationship, Drug; Eugenol; Humans; Mice; Tinea; Trichophyton | 2016 |
Hydroxychavicol inhibits immune responses to mitigate cognitive dysfunction in rats.
Topics: Administration, Oral; Amyloid Precursor Protein Secretases; Animals; Antigens, CD; Avoidance Learning; Blood Glucose; Blood Pressure; Brain; Chromatography, High Pressure Liquid; Cognition Disorders; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Eugenol; Flow Cytometry; Glutathione; Lipid Peroxidation; Male; Mice; Nitric Oxide; Rats; Rats, Wistar; Streptozocin; Sulfatases | 2010 |